Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|November 4, 2020
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic CancerOrnella Randazzo, Filippo Papini, Giulia Mantini, et al.
Cancers|February 11, 2023
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, et al.
Anticancer Research|July 3, 2019
To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical PharmacologyBtissame El Hassouni, Giulia Mantini, Giovanna Li Petri, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2025
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapyMahrou Vahabi, Geng Xu, Dzjemma Sarkisjan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 18, 2025
Spatial Analysis Identifies CD147 as a Novel Marker of High-Grade Childhood Posterior Fossa EpendymomaDonatella Lucchetti, Filomena Colella, Antonio d'Amati, et al.
Cancers|May 11, 2019
Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate CellsOmidreza Firuzi, Pei Pei Che, Btissame El Hassouni, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer CellsPei Pei Che, Alessandro Gregori, Cecilia Bergonzini, et al.
International Journal of Biological Sciences|June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic TargetRocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
European Journal of Medicinal Chemistry|October 12, 2020
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsCarlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
Cell Reports|June 3, 2023
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinomaAndrea Vallés-Martí, Giulia Mantini, Paul Manoukian, et al.
Pageof 3